64 related articles for article (PubMed ID: 7937748)
1. Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies.
Olafsen T; Munthe Lund CK; Bruland OS; Sandlie I; Michaelsen TE
Cancer Immunol Immunother; 1999 Oct; 48(7):411-8. PubMed ID: 10501855
[TBL] [Abstract][Full Text] [Related]
2. Coming together at the hinges: Therapeutic prospects of IgG3.
Chu TH; Patz EF; Ackerman ME
MAbs; 2021; 13(1):1882028. PubMed ID: 33602056
[TBL] [Abstract][Full Text] [Related]
3. Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry.
Woodall DW; Dillon TM; Kalenian K; Padaki R; Kuhns S; Semin DJ; Bondarenko PV
MAbs; 2022; 14(1):2004982. PubMed ID: 34978527
[TBL] [Abstract][Full Text] [Related]
4. Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies.
Shaw A; Hoffecker IT; Smyrlaki I; Rosa J; Grevys A; Bratlie D; Sandlie I; Michaelsen TE; Andersen JT; Högberg B
Nat Nanotechnol; 2019 Feb; 14(2):184-190. PubMed ID: 30643273
[TBL] [Abstract][Full Text] [Related]
5. Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation.
Soni KS; Desale SS; Bronich TK
J Control Release; 2016 Oct; 240():109-126. PubMed ID: 26571000
[TBL] [Abstract][Full Text] [Related]
6. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.
McCombs JR; Owen SC
AAPS J; 2015 Mar; 17(2):339-51. PubMed ID: 25604608
[TBL] [Abstract][Full Text] [Related]
7. Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'.
Schumacher FF; Sanchania VA; Tolner B; Wright ZV; Ryan CP; Smith ME; Ward JM; Caddick S; Kay CW; Aeppli G; Chester KA; Baker JR
Sci Rep; 2013; 3():1525. PubMed ID: 23519366
[TBL] [Abstract][Full Text] [Related]
8. Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding.
Lightle S; Aykent S; Lacher N; Mitaksov V; Wells K; Zobel J; Oliphant T
Protein Sci; 2010 Apr; 19(4):753-62. PubMed ID: 20120022
[TBL] [Abstract][Full Text] [Related]
9. Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.
Lu Y; Harding SE; Michaelsen TE; Longman E; Davis KG; Ortega A; Grossmann JG; Sandlie I; García de la Torre J
Biophys J; 2007 Dec; 93(11):3733-44. PubMed ID: 17704171
[TBL] [Abstract][Full Text] [Related]
10. Crystallohydrodynamics of protein assemblies: Combining sedimentation, viscometry, and x-ray scattering.
Lu Y; Longman E; Davis KG; Ortega A; Grossmann JG; Michaelsen TE; de la Torre JG; Harding SE
Biophys J; 2006 Sep; 91(5):1688-97. PubMed ID: 16766619
[TBL] [Abstract][Full Text] [Related]
11. The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.
Rasmussen IB; Lunde E; Michaelsen TE; Bogen B; Sandlie I
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10296-301. PubMed ID: 11517321
[TBL] [Abstract][Full Text] [Related]
12. Activation of complement by an IgG molecule without a genetic hinge.
Brekke OH; Michaelsen TE; Sandin R; Sandlie I
Nature; 1993 Jun; 363(6430):628-30. PubMed ID: 8510754
[TBL] [Abstract][Full Text] [Related]
13. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
Michaelsen TE; Aase A; Norderhaug L; Sandlie I
Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
[TBL] [Abstract][Full Text] [Related]
14. The structural requirements for complement activation by IgG: does it hinge on the hinge?
Brekke OH; Michaelsen TE; Sandlie I
Immunol Today; 1995 Feb; 16(2):85-90. PubMed ID: 7888072
[TBL] [Abstract][Full Text] [Related]
15. Role of IgG3 in Infectious Diseases.
Damelang T; Rogerson SJ; Kent SJ; Chung AW
Trends Immunol; 2019 Mar; 40(3):197-211. PubMed ID: 30745265
[TBL] [Abstract][Full Text] [Related]
16. One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.
Michaelsen TE; Brekke OH; Aase A; Sandin RH; Bremnes B; Sandlie I
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9243-7. PubMed ID: 7937748
[TBL] [Abstract][Full Text] [Related]
17. The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded.
Aase A; Sandlie I; Norderhaug L; Brekke OH; Michaelsen TE
Eur J Immunol; 1993 Jul; 23(7):1546-51. PubMed ID: 8325331
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
